Nike suspends contract with tennis star Maria Sharapova

Nike put its contract with Sharapova on hold after the tennis star failed a drug test investigation.

Share this article!

Sharapova “said the drug Meldonium, which she took for 10 years, was prescribed by a doctor and was not on the banned list until the rules changed on Jan. 1,” [USA Today] reported.

“She said she has a magnesium deficiency and a family history of diabetes. The drug has long been thought to be used by athletes, especially in Eastern Europe and Russia, to boost endurance and help recovery.”

(READ MORE: Portland Business Journal)

The tennis star failed the Australian Open test in January, according to USA Today.

Sharapova’s deal with Nike–that started in 2010–is worth $70 million over eight years, according to USA Today.

Sharapova, 28, has won five Grand Slam titles, including Wimbledon in 2004, her first Slam title. She ascended to No. 1 in the rankings in 2005 and later achieved a career Grand Slam by winning the U.S. Open in 2006, the Australian Open in 2008 and the French Open in 2012 and 2014.

She has amassed almost $37 million in career earnings, second only to Serena Williams, who has earned more than $75 million. But the Russian has made far more off than court thanks to lucrative endorsement deals.



Published in Categories News